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Background: The Sinorhizobium meliloti ExoS/ChvI two component regulatory system is required for N2-fixing
symbiosis and exopolysaccharide synthesis. Orthologous systems are present in other Alphaproteobacteria, and in
many instances have been shown to be necessary for normal interactions with corresponding eukaryotic hosts.
Only a few transcriptional regulation targets have been determined, and as a result there is limited understanding
of the mechanisms that are controlled by the system.
Results: In an attempt to better define the members of the regulon, we have applied a simple in vitro
electrophoretic screen for DNA fragments that are bound by the ChvI response regulator protein. Several putative
transcriptional targets were identified and three were further examined by reporter gene fusion experiments for
transcriptional regulation. Two were confirmed to be repressed by ChvI, while one was activated by ChvI.
Conclusions: Our results suggest a role for ChvI as both a direct activator and repressor of transcription. The
identities and functions of many of these genes suggest explanations for some aspects of the pleiotropic
phenotype of exoS and chvI mutants. This work paves the way for in depth characterization of the ExoS/ChvI
regulon and its potential role in directing bacteria-host relationships.
Keywords: Rhizobia, Response regulator, DNA-binding, Exopolysaccharide, Alfalfa nodulation, chvI regulon, Signal
transduction, Transcriptional regulation, DNA binding assayBackground
Two-component regulatory systems (TCRS) are the
most abundant and widespread transcriptional regula-
tors in bacteria, as indicated by the number of instances
of the Pfam PF00072 response regulator receiver domain
[1]. Bacterial genomes typically contain dozens to hun-
dreds of these systems [2]. Response regulator domains
of transcriptional regulatory proteins are phosphorylated
by cognate sensor histidine kinase proteins in response
to changes in environment or growth conditions [3].
This phosphorylation results in conformational change
of the response regulator protein, leading to transcrip-
tional activation or repression. Even with the recognized
importance of these systems, very few of them have been
characterized with regard to the signal input and the
regulatory targets.* Correspondence: tcharles@uwaterloo.ca
1Department of Biology, University of Waterloo, Waterloo, Ontario N2L 3G1,
Canada
Full list of author information is available at the end of the article
© 2013 Bélanger and Charles; licensee BioMed
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumThe ExoS/ChvI two-component regulatory system,
consisting of the membrane-spanning histidine protein
kinase ExoS and the response regulator ChvI, is found in
alphaproteobacterial genomes. In Agrobacterium tume-
faciens, the ChvG/ChvI system is vital for plant tumor
formation, and mutants are sensitive to acidic pH and
detergents [4]. The BvrS/BvrR system of Brucella abor-
tus is required for virulence [5] and has a broad impact
on cell envelope as well as carbon and nitrogen metabol-
ism [6]. The Bartonella henselae BatR/BatS system is
also involved in regulating virulence-associated genes
[7]. Analysis of a mutant of the ExoS homolog of Rhizo-
bium leguminosarum confirmed its requirement for suc-
cessful nodule invasion and nitrogen fixation [8]. This
mutant also had a destabilized outer membrane, associated
with reduction of ropB expression, as well as increased
accumulation of intracellular poly-3-hydroxybutrate (PHB),
and reduction in exopolysaccharide production. In all
cases studied, ExoS/ChvI TCRS and its orthologs play a
role, although not well understood, in the bacterial-host
interaction.Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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through a Tn5 insertion mutant that resulted in overpro-
duction of exopolysaccharide due to disruption of the
membrane-spanning portion of the protein, causing con-
stitutive activation of the kinase activity, thus resulting
in constant phosphorylation of ChvI [9]. Null mutants of
exoS and chvI are able to trigger the formation of nod-
ules, but those nodules do not develop normally and
they do not fix nitrogen [10]. The mutants do not grow
on complex or in liquid media, and cultivation on defined
agar-media is challenging, a condition that prompted an
early conclusion that exoS and chvI are essential for S.
meliloti viability [11]. A chvI deletion mutant demon-
strated enhanced motility, and reduction in PHB accu-
mulation, the opposite of what was found for a R.
leguminosarum exoS homolog mutant [12]. Similar to the
R. leguminosarum mutant [8], alterations in LPS were ob-
served. Also isolated in the Tn5 screen that yielded the
constitutively activated exopolysaccharide overproducing
exoS mutant was a mutant of exoR [9]. Evidence has been
provided to suggest a direct interaction of ExoR with ExoS
in the periplasm, with ExoR binding contributing to the
maintenance of ExoS in an inactive conformation [13].
Furthermore, it has been proposed that cleavage of ExoR
is induced by some yet unknown environmental signal
during infection of the host plant, and this might modu-
late its ability to bind ExoS [14], resulting in its activation
and regulation of the target genes.
The exoS gene is situated within an operon along with
hprK, part of an incomplete phosphotransferase system
(PTS) in Alphaproteobacteria. In S. meliloti, HprK is in-
volved in succinate mediated catabolite repression [15].
The establishment of a direct functional or regulatory
link between the incomplete PTS and the ExoS/ChvI
TCRS has been elusive, partly because the systems have
often been studied in isolation.
Given the pleotropic nature of the exoS and chvI null
mutants [10], investigation of gene expression using
transcriptomics and proteomics might prove less than
satisfactory, as the expression of many genes that are
not direct regulatory targets is likely to be altered due to
physiological changes in the cell. Indeed transcriptomics
have identified hundreds of genes whose expression is
affected by the exoS96::Tn5 mutation [16]. Comparison
of transcriptomes from two different chvI mutant strains
(gain-of-function versus reduced-function) narrowed the
set of genes regulated by ChvI and subsequently facili-
tated the identification by gel shift assays of three
intergenic regions binding ChvI [17] and the determin-
ation of an 11-bp-long putative ChvI binding motif.
However, for the majority of genes identified as being
differentially expressed in a ChvI dependent manner in
that study, including the succinoglycan synthesis genes,
no binding to upstream regions could be demonstrated.As an alternative, we applied a method to screen for DNA
fragments that were directly bound by the ChvI transcrip-
tional regulator. Analysis of these targets suggests impor-
tant metabolic pathways affected by ChvI regulation. In
return, these new findings directed us to uncover better
conditions for cultivation of the loss-of-function chvI mu-
tants. Further analyses with reporter gene fusion assays
confirmed the direct role of ChvI as a repressor for the
rhizobactin and SMc00261 operons. It also confirmed the
previously discovered direct activation of the msbA2
operon by ChvI. Methods developed here to identify
ChvI targets have proved to be efficient and could be
applied to other response regulators.
Results
Application of electrophoretic mobility shift assay to the
identification of ChvI-regulated genes
To better understand the role of ChvI as a response
regulator, it is necessary to identify genes whose tran-
scription is directly influenced by ChvI. To identify spe-
cific DNA sequences from plasmid or genomic DNA for
which ChvI might have binding affinity, we adapted a
method using the electrophoretic mobility shift principle
[18]. The plasmid DNA electrophoretic mobility shift
assay (PD.EMSA) and genomic DNA electrophoretic
mobility shift assay (GD.EMSA) methods involve incu-
bation of purified DNA-binding protein with fraction-
ated DNA, followed by electrophoresis through a native
polyacrylamide gel using sodium boric acid (SB) buffer.
In this study, the restriction endonuclease Bsp143I was
used for DNA fragmentation. The use of SB buffer, a
low conductivity medium, and a 14-cm gel as well as
running the gel for 3–6 hours at low voltage, allowed
unbound DNA fragments to migrate far from the top of
the gel while ChvI-bound fragments remained near the
wells (see Additional file 1). Inclusion of EDTA in the
buffer resulted in no retardation of electrophoretic mo-
bility suggesting an involvement of the putative Mg2+
site for ChvI-DNA interaction (see Additional file 2).
The slower migrating bands were excised from the gel,
purified, and cloned into pUC18 vector from which the
insert DNA could be sequenced from each end to deter-
mine the extent of each fragment.
Bsp143I-digested pTC198 plasmid DNA was used to
perform PD.EMSA (see Additional file 1). This pUC19
clone contains a 5-kb KpnI-fragment from S. meliloti
Rm1021 spanning across the entire chvI-hprK genomic
sequence including the intergenic region between pckA
and chvI [10]. This plasmid was employed to optimize
the method with a smaller number of fragments than
with genomic DNA, thus providing a better resolution
on the gel but also increasing the chances of binding to
areas surrounding chvI and exoS to test for possible
autoregulation of ExoS/ChvI. Regulation of the adjacent
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A. tumefaciens using reporter gene fusion assays [19],
therefore this experiment was also aimed at testing if S.
meliloti ChvI could bind upstream of pckA.
Following the excision of electrophoretic bands from
PD.EMSA of pTC198, DNA fragments were cloned into
BamHI-linearized pUC18 and sequenced from both
ends. Out of four inserts sequenced, three represent a
176-bp fragment (genomic origin from 48523 to 48699)
coding for the region upstream of SMc02753, including
its start codon. A single clone contained a 395-bp region
spanning the upstream sequence of chvI and past the
translational start site (genomic origin from 51887 to
52281). These results suggest that ChvI might autoregulate
its transcription but most importantly, it shows a direct
binding affinity between the ChvI and the upstream se-
quence of manXhpr operon part of the PTS system. The
ChvI binding to the 176-bp fragment was also confirmed
by performing a gel shift assay using a PCR-amplified
DNA fragment from pLB102 and the purified ChvI pro-
tein (data not shown). Further delineation of this binding
was not performed.
After GD.EMSA, the examination of 27 clones resulted
in the identification of a large number of additional
potential targets for ChvI regulation (Table 1). Fragments
ranged in size from 67 bp to 595 bp. Interestingly, the ma-
jority of fragments identified were found to be in pre-
dicted coding sequences rather than in intergenic regions.
Moreover, ChvI-binding fragments are widely distributed
across the genome and are not confined to a particular
metabolic pathway. Although no one fragment was identi-
fied more than once, two non-contiguous fragments that
are part of the same gene (rhtX) were independently
cloned and sequenced. Fragments from the exoS-chvI re-
gion were not among the sequenced clones. Reporter gene
fusions were used to confirm the chvI-regulated transcrip-
tion of three selected genes (see below). These genes were
selected based on their availability from a random fusion
library [20], to test a mix of inter and intra fragments and
to validate the previously described regulation of the
msbA2 gene cluster.
Potential functions of identified ChvI-regulated genes
Genes potentially regulated by ChvI are of diverse func-
tion (Table 1). Because DNA fragments binding ChvI are
often found within a coding sequence and not in
intergenic areas, it is difficult to predict if ChvI acts as an
activator of an adjacent gene or a repressor of the gene it
binds within. In several cases, such as the rhizobactin gene
cluster and the msbA2 gene cluster, the ChvI-binding frag-
ment is found in the first gene of what is predicted to be
an operon. Table 1 lists genes found closest to a ChvI-
binding DNA fragment but it is possible in many instances
that genes further downstream could be part of the sametranscript and also be ChvI-regulated. It is also important
to note that the sequenced fragments are a subset of
cloned fragments and other ChvI targets likely exist. Using
the list of potentially ChvI-regulated genes obtained, we
queried databases for functional relationships between
targets: MetaCyc [21], KEGG [22] and STRING 8.1 [23].
Based on these analyses, a number of functional linkages
may be made between some potential ChvI targets.
Two fragments (F15 and F6) are linked to lactose ca-
tabolism. One is found in front of the lacFGZ1K gene
cluster and the second is found in SMc00589 (a con-
served hypothetical protein), about 300 bp upstream of
gal (Smc00588). The lacFGZ1K gene cluster encodes
genes for lactose ABC-transporter and a β-galactosidase
(E.C. 3.2.1.23). β-D-galactose is degraded through the De
Ley-Doudoroff pathway in S. meliloti [24,25] and gal
codes for the galactose dehydrogenase (EC 1.1.1.48) of
this pathway.
Two other fragments (F7 and F5) suggest that ChvI is in-
volved in regulating phospholipid biosynthesis. One frag-
ment is found in SMc02076 (cls) and another one is found
in SMc00550, about 300 bp upstream of psd (SMc00551)
and followed by pssA (SMc00552). Cardiolipin is produced
in S. meliloti and the only gene coding for a cardiolipin
synthetase is cls [26]. Interestingly, this gene is located
about 1 kb downstream of the exoS-associated gene exoR.
Proteins encoded by psd (phosphatidylcholine decarboxyl-
ase) and pssA (phosphatidylserine synthase) are respon-
sible for the biosynthesis of phosphatidylethanolamine and
phosphatidylserine respectively, and both of these phos-
pholipids are also intermediates for phosphatidylcholine
biosynthesis [27]. Mutants of these genes exhibit deficien-
cies in alfalfa symbiosis [27]. Aside from phospholipids
synthesis, another link was found between SMc00550 and
msbA2 using STRING 8.1. These two genes are homologs
and might have similar functions. The fragment F8 found
in SMc00262, a putative 3-ketoacyl-CoA thiolase, followed
by SMc00261, a putative fatty-acid-CoA ligase, also sug-
gests regulation of lipid metabolism. These genes are puta-
tively involved in fatty acid β-oxidation.
ChvI was also found to bind fragments from genes in-
volved in peptide and methionine transport. A fragment
(F13) belongs to the upstream sequence of SMc03267
and four genes encoding a putative dipeptidase and a
putative dipeptide ABC-type transporter. Another frag-
ment (F19) is from SMb20478, part of a gene cluster
coding for another dipeptide ABC-transporter. MetN
involved in importing methionine also has a fragment
of its gene having affinity for ChvI.
A fragment found in thiC (F23) and another found in
hisB (F1) do not present a directly evident link between
the thiamine and histidine biosynthesis pathways they
are respectively involved in but there is an indirect meta-
bolic link that can be followed in MetaCyc, KEGG and
Table 1 DNA fragments recovered from GD.EMSA and genes potentially regulated by ChvI
Fragment Size Genomic origin Position Gene Function
(bp) From To Inter/intra-genic (location)
Chromosome
F1 129 60821 60949 intra SMc02574 (hisB) probable imidazoleglycerol-phosphate
dehydratase
F2 304 654156 654459 intra SMc02281
F3 595 1085493 1086087 intra SMc00051 (phaA2) probable Na(+)/H(+)-antiporter (upstream
mucR)
F4 152 1183131 1183282 intra SMc02637 (upstream lpsL and rkpK)
F5 139 1220301 1220439 intra SMc00550 ABC transporter ATP-binding
transmembrane protein (upstream psd and
pssA)
F6 142 1260626 1260767 intra SMc00589 (upstream gal)
F7 145 1639710 1639854 intra SMc02076 (cls) putative cardiolipin synthetase
transmembrane protein (downstream exoR;
upstream xthA2)
F8 236 1830765 1831000 intra SMc00262 putative 3-ketoacyl-CoA thiolase
F9 166 2587012 2587177 intra SMc02733
F10 256 2991422 2991677 intra SMc03993
F11 128 3117150 3117277 intra SMc03159 (metN) methionine import ATP-binding protein
F12 288 3303566 3303853 intra SMc02491
F13 184 3383057 3383240 inter SMc03267 putative dipeptidase (upstream ABC
transporter)
F14 143 3412878 3413020 inter SMc03297
pSymB
F15 184 1266 1449 inter & intra SMb21653 (lacF) lactose ABC transporter, permease
component
F16 148 43628 43775 inter SMb20032
F17 150 132970 133119 inter SMb20119 putative site-specific recombinase
F18 97 221089 221185 intra SMb20213 (upstream SMb20214)
F19 67 492546 492612 intra SMb20478 putative dipeptide ABC transporter
permease and ATP-binding protein
F20 143 938297 938439 intra SMb21188 putative acyltransferase (msbA2 operon)
F21 141 1091213 1091353 intra & inter SMb21151 /SMb21552 (aacC4) putative aminoglycoside 6′-N-
acetyltransferase
F22 221 1588216 1588436 intra SMb20574 putative maltodextrin α-D-
glucosyltransferase
F23 145 1634582 1634726 intra SMb20615 (thiC) thiamine biosynthesis protein
pSymA
F24 220 1186198 1186417 intra SMa2103 oxidoreductase
F25 212 1278398 1278609 intra SMa2295 penicillin-binding protein
F26 94 1305222 1305315 intra SMa2337 (rhtX) rhizobactin transporter
F27 148 1305714 1305861 intra SMa2337 (rhtX) rhizobactin transporter
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aminoimidazole ribonucleotide (AIR) and hydroxyme-
thylpyrimidine phosphate (HMP-P) in the thiamine
biosynthesis pathway (Figure 1). AIR is biosynthesized
from 5-phosphoribosyl 1-pyrophosphate (PRPP). PRPP
is also required for the synthesis of histidine. In STRINGthis link is made through pur genes, which code for
enzymes involved in purine synthesis. Pyrimidine, purine
and pyridine nucleotide synthesis pathways are all
dependent on the availability of PRPP.
Following these analyses, we could not find a direct
link between these potentially ChvI-regulated genes and
Figure 1 5-Phosphoribosyl 1-pyrophosphate (PRPP) metabolic pathway and the potential role of ChvI in regulating downstream
biosynthesis pathways. Grey boxes represent genes potentially regulated by ChvI. Uridine-5’-phosphate (UMP), uridine-5’-diphosphate (UDP),
uridine-5’-triphosphate (UTP), hydroxymethylpyrimidine phosphate (HMP-P), 4-amino-5-hydroxymethyl-2-methylpyrimidine-pyrophosphate
(HMP-PP), 4-methyl-5-(β-hydroxyethyl)thiazole phosphate (THZ-P), 5-phospho-β-D-ribosyl-amine (PRA), 5-phospho-ribosyl-glycineamide (GAR),
5’-phosphoribosyl-N-formylglycineamide (FGAR), 5-phosphoribosyl-N-formylglycineamidine (FGAM), 5-aminoimidazole ribonucleotide (AIR),
4-carboxyaminoimidazole ribonucleotide (CAIR), 5’-phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole (SAICAR), aminoimidazole
carboxamide ribonucleotide (AICAR), phosphoribosyl-formamido-carboxamide (FAICAR), inosine-5’-phosphate (IMP), phosphoribosyl-ATP (PR-ATP),
phosphoribosyl-AMP (PR-AMP), phosphoribosylformiminoAICAR-P (PRoFAR), phosphoribulosylformimino-AICAR-P (PRFAR),
D-erythro-imidazole-glycerol-phosphate (IGP).
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one of the most important phenotypes of the chvI mu-
tant strain [10]. This is absolutely consistent with other
experimental work that has failed to find direct binding
of ChvI to exopolysaccharide synthesis gene upstream
regions [17]. However, an indirect link is suggested from
the regulation of thiamine and histidine biosynthesis
(Figure 1). These pathways are inter-related with the
synthesis of pyrimidine and consequently the availability
of UTP required for the synthesis of UDP-glucose. Per-
haps the imbalance caused by deregulating thiamine and
histidine synthesis affects UDP-glucose synthesis and
therefore polysaccharide production. To test this hy-
pothesis, we added 0.1% uracil to the MM9-succinate
minimal media and this improved significantly the
growth of the chvI mutant strain, although still not to a
level comparable to the wild-type (Table 2). However, an
important finding from these experiments is that the
addition of uracil allows the chvI null mutant strain to
grow in liquid media. From carbon source utilization
analyses performed in a previous work [10], proline or
ornithine are good carbon sources for the chvI mutant
strains, therefore 0.1% proline was added to MM9-
succinate media supplemented also with 0.1% uracil.
This improved the growth of the mutant strain even fur-
ther (Table 2).
Confirmation of ChvI involvement in transcriptional
regulation of identified target genes
Having identified genes that might be regulated by ChvI
and conditions allowing the growth of the chvI mutant
strain in liquid media, we used strains from a S. meliloti
fusion library [20] to confirm the regulation at transcrip-
tional levels. The library had been constructed using a
vector that forms gene fusions to the reporter genes gfp
+/lacZ or gusA/tdimer2(12) depending on the orienta-
tion of the insert. Because of the possible involvement of
ChvI in regulating the S. meliloti lac operon, we selected
gusA fusion strains to measure transcriptional activity
using the β-glucuronidase assay. Gene fusions were
transduced into chvI mutant SmUW38 and into theTable 2 Growth rate constants of chvI261 mutant strain
grown in MM9-succinate liquid media and with the






none 0.182 ± 0.004 0.043 ± 0.003
uracil 0.167 ± 0.006 0.144 ± 0.004
uracil and proline 0.192 ± 0.003 0.161 ± 0.002
proline 0.201 ± 0.014 0.159 ± 0.025
Errors represent standard deviation.wild-type strain Rm1021, and then assayed for β-
glucuronidase activity and compared. These assays have
been applied to three operons identified by the DNA
binding assays, confirming the regulation of all three op-
erons by ChvI, and also demonstrating that ChvI can
function as either an activator or a repressor, depending
on the target gene. The transcription assay with a house-
keeping gene in the two genetic backgrounds (wild-type
versus chvI261) was not tested. However, we did
examine expression of the gene SMa2295 with a fusion
upstream of the ChvI binding site and the results
showed low and not significant GusA activity difference
between the two genotype backgrounds (23 versus 30
Miller Units).Figure 2 Transcriptional fusion assays and the msbA2 operon.
(A) GusA activities were measured for fusions in genes SMb21189,
SMb21190, and msbA2 in wild-type (Rm1021) and chvI261 mutant
(SmUW38) strain backgrounds. No GusA activities above background
levels were detected for fusions to SMb21189 and SMb21190 in the
chvI261 mutant strain background. (B) In the operon diagram, F1, F2,
and F3 represent the positions of the fusions to SMb21189,
SMb21190 and msbA2 respectively. The grey box (B) represents the
region for ChvI binding, and P1 and P2 are predicted promoters.
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SMb21188, the first gene of a predicted four-gene operon,
and therefore we tested three gene fusions to SMb21189,
SMb21190, and msbA2 (SMb21191) (Figure 2B). These
fusions had a much higher expression level in the wild-
type than in chvI mutant background (Figure 2A). These
results suggest that ChvI is responsible for activation of
the co-transcription of SMb21189, SMb21190, and msbA2
genes. Using a neural network promoter prediction tool
[28], we predicted a putative transcriptional start site (P2)
adjacent to the area containing a ChvI binding site (B).
Another putative transcriptional start site (P1) further up-
stream from SMb21188 suggests that transcription might
be directed from two differently regulated promoters, only
one of which would include the SMb21188 gene.
Reporter gene fusion assays and promoter prediction
were done with fusions in genes SMc00262 and SMc00261,Figure 3 Transcriptional fusion assays and the SMc00261
operon. (A) GusA activities were measured for fusions in genes
SMc00262 and SMc00261 in wild-type (Rm1021) and chvI261 mutant
(SmUW38) strain backgrounds. (B) In the operon diagram, F1 and F2
represent the position of the fusions to SMc00262 and SMc00261
respectively. The grey box (B) represents the region for ChvI binding,
and P1, P2 and P3 are predicted promoters.which are predicted to encode a 3-ketoacyl-CoA thiolase
and a fatty-acid-CoA ligase respectively (Figure 3B). In this
case, a promoter was predicted immediately upstream of
the ChvI binding area in SMc00262 and accordingly the
fusions further downstream in SMc00262 and in
SMc00261 presented higher expression levels in chvI
mutant strains than in wild type (Figure 3A). These re-
sults suggest that ChvI acts by repressing the transcrip-
tion of the SMc00264 – SMc00259 operon.
S. meliloti produces an iron-siderophore, rhizobactin
1021, under iron-depleted conditions [29]. Genes for the
synthesis and transport of rhizobactin are clustered in
an operon [30]. The rhizobactin transporter coding se-
quence (rhtX, SMa2337) was found to contain two DNA
fragments binding ChvI (Table 1 and Figure 4B). We
tested a fusion following the first binding site (B1) and two
other fusions further in rhbB (SMa2402; diaminobutyrateFigure 4 Transcriptional fusion assays and the rhizobactin
operon. (A) GusA activities were measured for fusions in genes rhtX,
rhbB and rhbF in wild-type (Rm1021) and chvI261 mutant (SmUW38)
strain backgrounds. (B) The rhizobactin genes are clustered in one
operon, F1 F2 and F3 represent the positions of the fusions to rhtX, rhtB,
and rhbF respectively. The grey boxes (B1 and B2) represent the possible
position for ChvI binding, and P1 and P2 are predicted promoters.
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promoter prediction suggests the presence of a promoter
before rhtX and another one before rhbA. The β-
glucuronidase assays presented a higher expression in chvI
background for all three fusions. This suggests that ChvI
represses the expression of genes required for the synthe-
sis and transport of rhizobactin 1021. Both binding areas
seem to be important in repressing the transcription as
shown by a higher expression in the fusion found before
the second binding.
The high basal level of the negatively regulated op-
erons is not really unexpected given that we do not
know the repressing conditions, and also the likelihood
of multiple regulatory systems acting on these genes.
These experiments involved the comparison of gene
expression in genetic backgrounds that resulted in differ-
ences only in the presence / absence of the ChvI regula-
tor. Otherwise, the environmental conditions were not
altered.Discussion
An adaptation of methods to perform gel electrophoresis
mobility shift assays allowed us to identify DNA frag-
ments with higher affinity for ChvI. Analyses of these re-
sults force us to revise our earlier perceptions following
phenotypic analyses of ExoS/ChvI as mainly a regulatory
system for exopolysaccharide production. Our results
suggest that the ChvI regulon includes genes from di-
verse pathways. Moreover, ChvI appears to have a dual
regulatory role, activating and repressing different op-
erons. The total number of targets likely far outnumbers
the 27 fragments that we pulled out in our screen, espe-
cially considering that we did not hit the same fragment
more than once, and we also did not find a few other
targets that had previously been shown to be bound by
ChvI.
The approach used in our study is highly complemen-
tary to the microarray and directed DNA binding study
of Chen et al. [17] that resulted in the identification of
several potential regulatory targets of ExoS/ChvI and the
prediction of a consensus binding sequence. It is import-
ant to note, however, that of 19 upstream regions tested,
binding was only detected to three (ropB1, SMb21440,
SMc01580), and a putative consensus sequence was de-
termined using some upstream regions to which binding
had not been demonstrated. Confirmation of this con-
sensus binding sequence awaits more detailed DNA
footprinting experiments on a larger number of identi-
fied targets. It is possible that many ChvI-repressed
genes may not have been detected in that study due to
the use of a constitutively activated variant of the ChvI
protein that might not have been able to function as a
repressor.The binding of ChvI within SMa2337 (rhtX) to repress
rhtXrhbABCDEF gene transcription could suggest that
following the sensing of a signal other than the presence
of iron, ExoS/ChvI represses genes for rhizobactin 1021
production. This operon is known to be upregulated by
RhrA in iron-depleted conditions [31] and downregulated
by RirA in iron-replete conditions [32]. Our fusion assay
results confirmed that the rhizobactin operon is highly
expressed in M9-minimal media (iron-depleted condi-
tions). However, this expression is even higher in strains
with the chvI null mutation. Iron is an important micro-
nutrient found in many cofactors required for cytochrome
and nitrogenase activity. Its acquisition however is difficult
for two main reasons. First, it is poorly soluble at pH 7,
and secondly, a high concentration of iron can cause the
generation of hydroxy radicals. Bacteria produce side-
rophores to scavenge iron and therefore control iron avail-
ability. A tight control over the production of siderophore
is thus important. The lack or the overproduction of
rhizobactin 1021 by S. meliloti impairs the symbiotic rela-
tionship with alfalfa [29]. Mutation of rirA derepresses
rhizobactin production and as a result causes a growth de-
fect of the strain relative to the presence of iron [33]. The
reduced viability of the rirA mutant due to oxidative stress
suggested that perhaps this strain would also be affected
in its symbiotic properties but it was not the case [33].
This study suggested that in planta another unknown
regulatory system might control the production of
rhizobactin. Whether ExoS/ChvI might be the system re-
sponsible awaits further investigation.
Another important finding is the confirmation that
ChvI is involved in activation of the expression of
SMb21189, SMb21190, and msbA2. These genes have
only been described recently in the literature although
msbA2 in particular may play an important but incom-
pletely defined role in symbiosis [34,35], and the operon
has already been shown to be subject to ChvI regulation
[17]. SMb21189 and SMb21190 encode glycosyltransferases
and msbA2 is part of an ABC-transporter family involved
in macromolecule export. The above mentioned recent
studies proposed that the operon including SMb21188, a
putative acyltransferase, is involved in the production and
export of an unknown polysaccharide which uses inter-
mediates from the succinoglycan production pathway.
The regulation of this operon by ExoS/ChvI is therefore
the closest link to the succinoglycan-deficient phe-
notype of exoS and chvI mutant strains. Although this
ChvI-regulated operon is not required for succinoglycan
production it seems to be functionally related to
succinoglycan production.
The third operon that we confirmed to be differentially
regulated by ChvI encodes proteins putatively involved
in fatty acid β-oxidation. SMc00262 putatively produces
a 3-ketoacyl-CoA and SMc00261, a fatty-acid-CoA
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coding for a putative short-chain dehydrogenase and
SMc00259 coding for a hypothetical protein. Upstream
of these genes lay genes for a transcriptional regulator of
the IclR family (SMc00263) and another short-chain
dehydrogenase (SMc00264). Our earlier studies failed to
demonstrate a phenotype for SMc00260 and SMc00264
mutants [36]. A tripartite ATP-independent periplasmic
(TRAP) transporter system upregulated by the presence
of acetoacetate and 3-methyl oxovaleric acid is encoded
by genes in the same orientation upstream of SMc00264
[37]. All these genes are organized in the same orienta-
tion and close enough to each other to be part of the
same transcript. However, our finding of a ChvI binding
site in SMc00262, after the gene encoding the IclR regu-
lator, suggests a complex regulation of these genes. In
fact, a N-Acyl homoserine lactone (AHL) also impacts
on their expression [38]. The fatty-acid-CoA ligase
(SMc00261) has been found differentially accumulated
in early log phase cultures of S. meliloti Rm1021 treated
for 2 hours with 3-oxo-C16:1-HL while the periplasmic
binding protein (SMc00265) accumulated in stationary
phase cultures independently of the presence of AHLs.
Perhaps under conditions that activate ChvI, the first
part of the gene cluster is upregulated to allow the
import of an organic acid but the second part respon-
sible for its degradation and entry in the TCA cycle is
downregulated. This hypothesis would suggest the use of
this organic acid, under certain conditions, as a readily
available building block rather than an energy source.
An important finding from this work is that uracil and
proline improved the growth of the chvI mutant. This
finding now allows us to culture the mutant strain in
liquid media, greatly facilitating experimental analysis.
Binding of ChvI in thiC (SMb20615) and in hisB
(SMc02574), perhaps to repress the thiamine and histi-
dine biosynthesis operons, made us hypothesize that a
derepression of these operons in exoS or chvI mutants
could lead to a deficiency in UTP formation and could
explain the pleiotropy of these mutants. Rhizobial purine
and pyrimidine auxotrophic mutants have been found
affected in polysaccharides synthesis and plant invasion
[39-42]. Further work needs to be done to confirm that
chvI mutant auxotrophy is truly caused by a derepres-
sion of operons for thiamine and histidine biosynthesis.
Conclusions
We have identified a number of putative direct targets of
ChvI, many of which are consistent with the pleotropic
phenotype of exoS and chvI mutants. We also demon-
strated that ChvI may act as a repressor or activator of
gene expression, and surprisingly ChvI seems to often
bind within predicted protein coding sequences. The
bias is often to only consider intergenic regions forlocations of potential regulatory sites. However, we note
that the Fur regulator of Helicobacter pylori is just one
example of a transcriptional regulatory protein that has
targets within polycistronic operons and acts as a repres-
sor and an activator of gene expression [43]. The tendency
to search for transcriptional cis-regulatory elements in
intergenic areas rather than considering equally regions
internal to ORFs may need to be revisited. GD.EMSA or
Chromatin-Immunoprecipitation (ChIP) techniques are
examples of techniques that do not have a bias towards
intergenic or intragenic areas and their usage certainly
make important contributions to our knowledge about
transcriptional regulation.
Although this study has uncovered new facets of the
ExoS/ChvI regulation, the regulatory signal is still un-
known. However, a number of new hypotheses emerge.
Several genes identified in this study as possibly ChvI-
regulated are involved in amino acid and peptide metab-
olism and transport. In Rhizobium leguminosarum bv.
viciae VF39SM, peptides have been shown to increase
the expression of the outer membrane protein ropB in a
ChvG-dependent manner [44]. Perhaps ExoS and/or
ExoR sense(s) peptides. Also, our work suggests a direct
regulatory link between the PTS and the ExoS/ChvI sys-
tems; do these systems partner to coordinate the C and N
metabolism as suggested by recent work in B. melitensis
[45]? With several putative ChvI-targeted genes now iden-
tified, tools necessary to test these hypotheses are avail-
able. We are cognizant, however, of the fact that our
screen was not saturating, and we will endeavor to adapt
the method for higher throughput so that we have a better
understanding of the complete ChvI regulon and the na-
ture of the ChvI consensus binding sequence.
Methods
Bacterial strains, plasmids and growth conditions
Strains and plasmids used in this study are listed in
Table 3. Growth conditions are as described previously
[10] or as described in subsequent procedures.
Cloning of chvI for His•Tag-ChvI expression and purification
S. meliloti Rm1021 chvI was PCR amplified using primers
LB5 and LB6 (Table 3). The 800-bp PCR fragment was
gel-purified and then cloned in pGEM®-T Easy vector.
Plasmid pLB010 with the insert in the correct orientation
for expression was verified by DNA sequence analysis.
NotI chvI-containing fragment was then cut out of
pLB010 and ligated to NotI-digested pET-30a, generating
a N-terminal His•Tag fusion pJF011. E. coli BL21(DE3)
pLysS clones carrying the pJF011 plasmid were confirmed
for His•Tag-ChvI production by western blot using a
His•Tag monoclonal antibody from mouse (Novagen) and
Alexa Fluor 488 goat anti-mouse IgG (H + L) (Invitrogen,
Molecular Probes) as the secondary antibody. His•Tag-








Rm1021 SU47 str-21, Smr wild type [46,47]
SmUW38 Rm1021 chvI::nptII (chvI261) [10]
SmFL430 RmP110 SMa2295::pTH1522 [20]
SmFL112 RmP110 msbA2::pTH1522 [20]
SmFL4665 RmP110 SMb21189::pTH1522 [20]
SmFL5401 RmP110 SMb21190::pTH1522 [20]
SmFL918 RmP110 SMc00262::pTH1522 [20]
SmFL4392 RmP110 SMc00261::pTH1522 [20]
SmFL2950 RmP110 rhbB::pTH1522 [20]
SmFL5628 RmP110 rhtX::pTH1522 [20]
SmFL5755 RmP110 rhbF::pTH1522 [20]
SmUW45 Rm1021 SMa2295::pTH1522 This study
SmUW43 Rm1021 msbA2::pTH1522 This study
SmUW58 Rm1021 SMb21189::pTH1522 This study
SmUW59 Rm1021 SMb21190::pTH1522 This study
SmUW46 Rm1021 SMc00262::pTH1522 This study
SmUW57 Rm1021 SMc00261::pTH1522 This study
SmUW55 Rm1021 rhbB::pTH1522 This study
SmUW62 Rm1021 rhtX::pTH1522 This study
SmUW63 Rm1021 rhbF::pTH1522 This study
SmUW157 SmUW38 SMa2295::pTH1522 This study
SmUW133 SmUW38 msbA2::pTH1522 This study
SmUW148 SmUW38 SMb21189::pTH1522 This study
SmUW149 SmUW38 SMb21190::pTH1522 This study
SmUW136 SmUW38 SMc00262::pTH1522 This study
SmUW147 SmUW38 SMc00261::pTH1522 This study
SmUW145 SmUW38 rhbB::pTH1522 This study
SmUW152 SmUW38 rhtX::pTH1522 This study
SmUW153 SmUW38 rhbF::pTH1522 This study
Escherichia coli




deoR, thi-1, supE44, λ-, gyrA96,
relA1
[48]
BL21(DE3)pLysS F−, ompT, hsdSB (rB
- , mB




pGEM®-T Easy Cloning of PCR products, Ampr Promega (USA)
pET-30a(+) His•Tag expression vector, Kmr EMD Chemicals
(Novagen)
pLB010 pGEM®-T Easy::chvI, Ampr This study
pJF011 pET-30a(+)::chvI, Kmr This study
pUC18 Cloning vector, Ampr [50]
Table 3 Bacterial strains, plasmids and primers used in
this study (Continued)
pTC198 pUC19::5-kb chvI-exoShrpK, Ampr [10]
pTC190 pVK101::4kb A. tumefaciens chvI/
G, Tcr Kmr
[4]
pKNG101 sacB+ mobRK2 oriR6K, Sm
r [51]
pKD001 pTC190::pKNG101, Tcr This study
Primer Sequence (5′-3′)
LB5 atgcagaccatcgcgctt This study
LB6 acatcgtgatccaacaagg This study
LB61 gtaaaacgacggccagt This study
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was performed in the laboratory of Professor Bi-Cheng
Wang at University of Georgia (USA).
Electrophoretic mobility shift assay using genomic DNA
(GD.EMSA)
To prepare samples, S. meliloti Rm1021 genomic DNA
was digested to completion by overnight incubation
with Bsp143I restriction enzyme (Sau3AI isoschizomer,
Fermentas Life Sciences, Canada) and the reaction was
then heat-inactivated. Purified His•Tag-ChvI protein
was mixed with digested DNA in a solution of 9% gly-
cerol, 3 mM acetyl phosphate, 0.8 mM Tris-acetate,
0.25 mM magnesium acetate, 1.65 mM potassium acet-
ate, 2.5 μg ml-1 bovine serum albumin (BSA). For nega-
tive controls, ChvI protein was not added to samples.
Incubations were carried out for 30 minutes at room
temperature and loaded directly on gel without dye.
To perform the electrophoresis, a sodium boric acid
buffer (SB buffer) was made following the specifications
of Brody and Kern [52]. 5% nondenaturing polyacryl-
amide gels (14 cm × 16 cm) were cast using a Hoefer SE
600 gel electrophoresis unit and following the standard
procedure for resolution of small DNA fragments [53]
but using SB buffer instead of TBE buffer. Gels were run
in 1X SB buffer between 25 to 40 mA for 3–6 hours.
Gels were then stained for 1 hour in a 3X GelRed™
staining solution containing 0.1 M NaCl and following
manufacturer’s recommendation for post gel staining
(Biotium, USA, CA) prior to visualization on a UV
transilluminator. Shifted DNA bands in the highest part
of the gel were then excised and stored in 2-ml plastic
tubes at −20°C.
To recover DNA fragments from polyacrylamide gel,
the method from Ausubel et al. (1992) [53] was used.
The elution buffer used contained 0.5 M ammonium
acetate, 1 mM EDTA, 0.1% SDS and final pH 8. 200 μl
elution buffer was added to each tube containing a piece
of gel. The gel was then crushed in smaller pieces using
a pipet tip. Tubes were incubated overnight at 37°C with
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room temperature for 10 minutes at 10,000 rpm, super-
natant was removed and transferred to a clean 2.0 ml
tube. Ethanol (500 μl) was added to precipitate the DNA
and tubes were placed at −20°C overnight. DNA was
pelleted at 13,000 rpm for 10 minutes. Supernatant was
removed and DNA solubilized in 100 μl of 10 mM Tris
pH 8 and 15 μl of 5 M sodium chloride was added.
DNA was then precipitated a second time with 2 volumes
of ethanol and kept overnight at −20°C. Precipitated DNA
was recovered by centrifugation in a microcentrifuge at
13,000 rpm for 15 minutes, supernatant was removed and
DNA was dried. Final resuspension of DNA was done
with 10 μl of 10 mM Tris pH 8.
The DNA fragments were cloned into the BamHI site
in pUC18. Prior to ligation, BamHI-digested pUC18 was
dephosphorylated using shrimp alkaline phosphatase
(Fermentas Inc.) and the reaction stopped by heat-
inactivation. Ligation was performed overnight at room
temperature with T4 DNA ligase (Fermentas Inc.).
Transformation of calcium chloride competent E. coli
DH5α cells was done following standard procedure [54].
Over 40 transformant colonies were streak-purified from
each experiment. A selection of them were then used for
plasmid preparation and tested for the presence of an in-
sert using restriction digest with EcoRI and PstI. Frag-
ments cloned in pUC18 were sequenced using primers
M13F provided by the sequencing facility (University of
Waterloo) or LB61 (Table 3).
Sequences were first analyzed by searching for Sau3AI
(Bsp143I) restriction sites to determine the limits of each
fragment. Each fragment sequence was then searched
against S. meliloti Rm1021 genomic sequence using the
BLAST tool from Toulouse annotation website [55].
Genes in closest proximity to identified sequences and
potentially regulated by ChvI were searched against
STRING 8.1 databases (June 28, 2009) for functional re-
lations [23]. The search was directed from the Toulouse
annotation website.
Reporter gene fusion strains
Transcriptional fusion strains were obtained by trans-
duction from the reporter gene fusion library strains
made by Cowie et al. [20]. SmFL strains were used to
prepare transduction lysates to transfer the gene fusions
from the original S. meliloti RmP110 background into
the Rm1021 background. Selection of transductants was
done on LB with gentamicin (60 μg ml-1). The same
lysates were also used to transduce gene fusions into
SmUW38 (pKD001) with selection on LB gentamicin
(60 μg ml-1) and neomycin (200 μg ml-1). Four transduc-
tants per transduction experiment were picked and
streaked on LB gentamicin and neomycin. Transduc-
tants were then cured of pKD001 by streaking them onMM9-succinate gentamicin (20 μg ml-1) containing 2.5%
sucrose and incubated at 30°C for four days. pDK001-
cured strains were finally streaked on MM9-succinate
gentamicin.
Phage ΦM12 was used for transductions following the
usual procedure [56], except that TY media was used in-
stead of LBmc media to prepare and dilute lysates. High
yield of transductants required the use of Bacto™-Agar, -
Tryptone, and -Yeast extract (BD). Diluted lysate (0.5 ml)
was mixed with equal volume of cell suspension and incu-
bated at room temperature for 30 minutes. Cells were
then recovered by centrifugation in a microcentrifuge for
10 minutes and washed twice with 2 ml of saline. Final
resuspension was done with 400 μl saline and then
spread on two agar plates. Plates were incubated at 30°C
for four days.
Growth in liquid media
Inocula were prepared by resuspending bacterial bio-
mass from MM9-succinate-agar plates into a saline solu-
tion (0.85% NaCl) to obtain an optical density (OD600)
of 0.8. Test tubes containing 5-ml liquid media made of
MM9-succinate with/without 0.1% proline and/or 0.1%
uracil where inoculated with the inoculum at a 10% con-
centration. Test tubes were incubated at 30°C with con-
stant shaking. Growth was monitored by reading the
absorbance at 600 nm. Growth rate constants (μ) were
calculated based on absorbance values during the expo-
nential growth phase and using the formula: μ = ( (log10
N - log10 N0) 2.303) / (t - t0). Results represent the aver-
age of duplicates and the standard deviation was calcu-
lated as the error.
β-Glucuronidase assay
To measure transcription from reporter gene fusion
strains, the β-glucuronidase assay described in Cowie et al.
[20] was adapted. Strains were grown in MM9-succinate
plus 0.1% proline, 0.1% uracil, and gentamicin until OD600
of 0.2 - 0.8. These cells were then used directly for the
assay in microplates as described previously [20]. Assays
were done in triplicate and standard deviation calculated.
Additional files
Additional file 1: Gel image of PD.EMSA to compare DNA shifts
on 6-cm versus 14-cm 5% nondenaturing polyacrylamide gel
and using SB buffer. Prior to the electrophoresis, the Bsp143I
restricted pTC198 plasmid was incubated or not with the HisTag-ChvI
protein.
Additional file 2: Gel image of PD.EMSA to compare ChvI binding
specificity in presence of EDTA or acetylphosphate. A 5%
nondenaturing polyacrylamide gel made with TB buffer was used for the
electrophoresis of the EcoRI-PstI double restricted pLB102 plasmid. The
plasmid DNA was incubated or not with HisTag-ChvI protein in presence
or not of EDTA and in presence or not of acetylphosphate (AP) prior to
the electrophoresis.
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